Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6198176rdf:typepubmed:Citationlld:pubmed
pubmed-article:6198176lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C0000376lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C0025741lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:6198176lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:6198176pubmed:dateCreated1984-3-23lld:pubmed
pubmed-article:6198176pubmed:abstractTextCerebrospinal fluid (CSF) was removed at a constant flow rate of 1 microliter min-1 from the third ventricle of rats and directly analyzed by liquid chromatography coupled with electrochemical detection. The effect of alphamethyldopa (alpha MD) on CSF alpha MD, dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindolacetic acid (5-HIAA) concentrations was studied for 5 h. alpha MD ethyl ester administration resulted in higher alpha MD levels in CSF as compared with alpha MD administration, suggesting a higher bioavailability of the ethyl ester vs the free acid. A specific inhibition of dopamine metabolism was reflected by a reduction in DOPAC levels while 5-HIAA concentrations were unchanged.lld:pubmed
pubmed-article:6198176pubmed:languageenglld:pubmed
pubmed-article:6198176pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6198176pubmed:citationSubsetIMlld:pubmed
pubmed-article:6198176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6198176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6198176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6198176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6198176pubmed:statusMEDLINElld:pubmed
pubmed-article:6198176pubmed:monthNovlld:pubmed
pubmed-article:6198176pubmed:issn0195-668Xlld:pubmed
pubmed-article:6198176pubmed:authorpubmed-author:MeyerPPlld:pubmed
pubmed-article:6198176pubmed:authorpubmed-author:ElghoziJ LJLlld:pubmed
pubmed-article:6198176pubmed:authorpubmed-author:MignotEElld:pubmed
pubmed-article:6198176pubmed:authorpubmed-author:LaudeDDlld:pubmed
pubmed-article:6198176pubmed:issnTypePrintlld:pubmed
pubmed-article:6198176pubmed:volume4 Suppl Glld:pubmed
pubmed-article:6198176pubmed:ownerNLMlld:pubmed
pubmed-article:6198176pubmed:authorsCompleteYlld:pubmed
pubmed-article:6198176pubmed:pagination31-4lld:pubmed
pubmed-article:6198176pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:meshHeadingpubmed-meshheading:6198176-...lld:pubmed
pubmed-article:6198176pubmed:year1983lld:pubmed
pubmed-article:6198176pubmed:articleTitleDetermination of alphamethyldopa, dihydroxyphenylacetic acid and 5-hydroxyindolacetic acid in the cerebrospinal fluid of the rat: kinetic study.lld:pubmed
pubmed-article:6198176pubmed:publicationTypeJournal Articlelld:pubmed